Stock LEXX LEXARIA BIOSCIENCE CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Lexaria Bioscience Corp.

Equities

LEXX

US52886N4060

Real-time Estimate Cboe BZX
Other stock markets
 18:18:01 15/05/2024 BST 		5-day change 1st Jan Change
3.085 USD +0.16% Intraday chart for Lexaria Bioscience Corp. -13.56% +144.80%
05-08 Lexaria Bioscience Corp. Begins Dosing of Its Second Glp-1 Human Pilot Study CI
04-16 Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lexaria Bioscience Names Nelson Cabatuan as Finance Chief
MT
Lexaria Bioscience Appoints Mike Shankman as CFO
MT
Lexaria Bioscience Corp. Appoints Chris Bunka as Principal Financial Officer
CI
Lexaria Bioscience Corp. Appoints Julian Gangolli as Strategic Advisor
CI
Lexaria Bioscience Corp. Appoints Dr. Catherine Turkel to its Board of Directors
CI
Brian Quigley Will Not Stand for Re-Election of Lexaria Bioscience Corp.'s Board
CI
Lexaria Bioscience Corp. Elects Ted Mckechnie as A Director
CI
Brian Quigley, Director of Lexaria Bioscience Corp. Determines Not to Stand for Re-Election
CI
Lexaria Bioscience Corp. Appoints Gregory Downey as Chief Financial Officer
CI
Lexaria Bioscience : DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network
PU
Lexaria Bioscience : DehydraTECH(TM) Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network
AQ
Lexaria Bioscience Corp. Appoints Al Reese as Board of Director
CI
Lexaria Bioscience Corp. Appoints Gregg Smith, Founder of Evolution VC Partners, as Senior Advisor
CI
Lexaria Bioscience Corp. Appoints Brian Quigley to its Board of Directors
CI
Lexaria Bioscience Corp. Elects Ted Mckechnie as Director
CI
Lexaria Bioscience Corp. Expands Advisory Board
CI
Lexaria Bioscience Submits Application to Health Canada for Research License; Appoints Ed Ergenzinger as Chief Legal Officer and Senior Vice President of Innovation
CI
Lexaria Bioscience Corp Appoints Allan Spissinger as New Acting CFO, Secretary and Treasurer
CI
Lexaria Corp. will Change its Name to Lexaria Bioscience Corp
CI
Lexaria Corp. Announces Executive Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LEXX Stock
  4. News Lexaria Bioscience Corp.
  5. Insiders